Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer

Background. We investigated the correlation between genetic mutations and clinical-pathological features in young patients with NSCLC. Methods. Clinicopathologic information of 102 young NSCLC patients was collected. Direct ctDNA sequencing of a portion of these patients was performed. The correlati...

Full description

Saved in:
Bibliographic Details
Main Authors: Wencui Kong, Zongyang Yu, Wenwu Wang, Jingrong Yang, Jingfang Wang, Zhongquan Zhao
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Emergency Medicine International
Online Access:http://dx.doi.org/10.1155/2022/6333282
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558353490903040
author Wencui Kong
Zongyang Yu
Wenwu Wang
Jingrong Yang
Jingfang Wang
Zhongquan Zhao
author_facet Wencui Kong
Zongyang Yu
Wenwu Wang
Jingrong Yang
Jingfang Wang
Zhongquan Zhao
author_sort Wencui Kong
collection DOAJ
description Background. We investigated the correlation between genetic mutations and clinical-pathological features in young patients with NSCLC. Methods. Clinicopathologic information of 102 young NSCLC patients was collected. Direct ctDNA sequencing of a portion of these patients was performed. The correlation between EGFR mutation and ALK fusions with clinicopathologic parameters was analyzed. Results. In young NSCLC patients, adenocarcinoma is the major histology (86.9%), and the misdiagnosis rate was as high as 45.7%. EGFR gene mutation was found in 13 patients (31.7%) and common mutations were with EGFR19del mutation (7 cases, 17.1%) and EGFR21L858R mutation (4 patients, 9.7%). EGFR mutation was constantly found in adenocarcinoma and male gender, and ever smokers (100%, P<0.05). Furthermore, ALK fusions were found in 7 patients (31.8%), which include EML-4-ALK fusions; there was a trend that ALK fusions were associated with adenocarcinoma and female gender. However, there was no significant difference in overall survival between patients with or without gene mutations. Conclusions. EGFR mutation and ALK fusions are related to histology, gender, and smoke exposure in young NSCLC patients, and may be effective predictive factors.
format Article
id doaj-art-ef945658850a4d92a8f55a1de81c5862
institution Kabale University
issn 2090-2859
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Emergency Medicine International
spelling doaj-art-ef945658850a4d92a8f55a1de81c58622025-02-03T01:32:36ZengWileyEmergency Medicine International2090-28592022-01-01202210.1155/2022/6333282Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung CancerWencui Kong0Zongyang Yu1Wenwu Wang2Jingrong Yang3Jingfang Wang4Zhongquan Zhao5Department of Pulmonary and Critical Care MedicineDepartment of Pulmonary and Critical Care MedicineDepartment of OncologyDepartment of Thoracic SurgeryMedical School of RehabilitationDepartment of Pulmonary and Critical Care MedicineBackground. We investigated the correlation between genetic mutations and clinical-pathological features in young patients with NSCLC. Methods. Clinicopathologic information of 102 young NSCLC patients was collected. Direct ctDNA sequencing of a portion of these patients was performed. The correlation between EGFR mutation and ALK fusions with clinicopathologic parameters was analyzed. Results. In young NSCLC patients, adenocarcinoma is the major histology (86.9%), and the misdiagnosis rate was as high as 45.7%. EGFR gene mutation was found in 13 patients (31.7%) and common mutations were with EGFR19del mutation (7 cases, 17.1%) and EGFR21L858R mutation (4 patients, 9.7%). EGFR mutation was constantly found in adenocarcinoma and male gender, and ever smokers (100%, P<0.05). Furthermore, ALK fusions were found in 7 patients (31.8%), which include EML-4-ALK fusions; there was a trend that ALK fusions were associated with adenocarcinoma and female gender. However, there was no significant difference in overall survival between patients with or without gene mutations. Conclusions. EGFR mutation and ALK fusions are related to histology, gender, and smoke exposure in young NSCLC patients, and may be effective predictive factors.http://dx.doi.org/10.1155/2022/6333282
spellingShingle Wencui Kong
Zongyang Yu
Wenwu Wang
Jingrong Yang
Jingfang Wang
Zhongquan Zhao
Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
Emergency Medicine International
title Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
title_full Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
title_fullStr Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
title_full_unstemmed Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
title_short Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
title_sort gene mutation and its association with clinicopathological features in young patients with non small cell lung cancer
url http://dx.doi.org/10.1155/2022/6333282
work_keys_str_mv AT wencuikong genemutationanditsassociationwithclinicopathologicalfeaturesinyoungpatientswithnonsmallcelllungcancer
AT zongyangyu genemutationanditsassociationwithclinicopathologicalfeaturesinyoungpatientswithnonsmallcelllungcancer
AT wenwuwang genemutationanditsassociationwithclinicopathologicalfeaturesinyoungpatientswithnonsmallcelllungcancer
AT jingrongyang genemutationanditsassociationwithclinicopathologicalfeaturesinyoungpatientswithnonsmallcelllungcancer
AT jingfangwang genemutationanditsassociationwithclinicopathologicalfeaturesinyoungpatientswithnonsmallcelllungcancer
AT zhongquanzhao genemutationanditsassociationwithclinicopathologicalfeaturesinyoungpatientswithnonsmallcelllungcancer